A study out of Harvard found cannabis (the non-psychedelic component of marijuana) to decrease tumor size is mice afflicted with pancreatic cancer by 70%.
The researchers from Dana-Farber Cancer Institute found a small chemical within cannabis called FBL-0G3, also known as a flavanoid, a naturally occurring substance in many plants responsible for their vibrant color, and known for its antiiflammatory properties.
When mice with pancreatic cancer were given the FBL-0G3 along with radiation, their tumors shrank and in many, stopped growing. The FBL-03G anticancer properties were also witnessed in a lab setting when combined with pancreatic cells in a petrie dish.
The findings demonstrate the potential for this new cannabis derivative in the treatment of both localized and advanced pancreatic cancer, providing impetus for further studies toward clinical translation.
Each year over 56,000 Americans are diagnosed with pancreatic cancer, whose 5-year survival rate is 5%. Older individuals who are healthy can do as well as those who are younger when diagnosed with advanced stage of the disease. However some sources cite the median survival time is between 2 and 6 months if the cancer is diagnosed at a late stage.
What are the risk factors for pancreatic cancer?
Known risk factors for pancreatic cancer include:
- Older individuals
- Male (though women are affected as well)
- Alcohol use
- Chronic pancreatitis
- African-American descent
- Ashkenazi Jewish descent
- High fat diet
- Hepatitis B
- H. pylori infection
- BRCA1 or BRCA2 mutations
Can Diet Soda CAUSE Diabetes?
Artificial sweeteners have been linked to diabetes and diabetes is a risk factor for pancreatic cancer. Their relationship to pancreatic cancer, however, still remains controversial.